AC Immune S.A.

ACIU · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$36,275$78,494$31,586$82,216
Short-Term Investments$129,214$24,554$91,000$116,000
Receivables$1,099$15,046$408$975
Inventory$0$0$0$0
Other Curr. Assets$5,406$7,059$5,100$3,443
Total Curr. Assets$171,994$125,153$128,094$202,634
Property Plant & Equip (Net)$8,088$6,884$7,067$8,030
Goodwill$0$0$0$0
Intangibles$50,416$50,416$50,416$50,416
Long-Term Investments$0$361$0$0
Tax Assets$0$0$0$0
Other NC Assets$415$0$361$363
Total NC Assets$58,919$57,661$57,844$58,809
Other Assets$0$0$0$0
Total Assets$230,913$182,814$185,938$261,443
Liabilities
Payables$2,658$1,679$929$2,003
Short-Term Debt$1,026$672$548$570
Tax Payable$0$0$0$0
Deferred Revenue$0$138$0$0
Other Curr. Liab.$97,154$11,087$10,004$17,453
Total Curr. Liab.$100,838$13,576$11,481$20,026
LT Debt$4,401$2,825$2,253$2,340
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,404$5,770$3,213$7,098
Total NC Liab.$17,805$8,595$5,466$9,438
Other Liabilities$0$0$0$0
Cap. Leases$5,427$3,497$2,801$2,910
Total Liabilities$118,643$22,171$16,947$29,464
Equity
Pref Stock$0$0$0$0
Common Stock$2,226$2,089$1,797$1,794
Retained Earnings-$368,239-$316,197-$264,015-$200,942
AOCI-$5-$51$10$0
Other Equity$478,288$474,802$431,199$431,127
Total Equity$112,270$160,643$168,991$231,979
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$230,913$182,814$185,938$261,443
Net Debt-$30,848-$74,997-$28,785-$79,306